Linagliptin 2.5 mg """

Linagliptin 2.5 mg
LINALIGLIP is a medication primarily used to treat type 2 diabetes. LINALIGLIP belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors or gliptins. LINALIGLIP works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). GLP-1 helps regulate blood sugar levels by increasing insulin secretion and decreasing the release of glucagon, a hormone that raises blood sugar.
LINALIGLIP inhibits the enzyme DPP-4, which prolongs the activity of GLP-1 and other incretin hormones. This results in improved blood sugar control by increasing insulin secretion, reducing glucagon release, and slowing down the absorption of glucose from the gut.
LINALIGLIP is available in strengths of 2.5mg and 5mg .
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-134280